FDA Inspection
Swiss Pharmaceutical Company LtdSwiss Pharmaceutical Company Ltd – FDA Inspection, Mar 22, 2019
Record Details
This FDA Inspection record concerns Swiss Pharmaceutical Company Ltd, with an inspection on March 22, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · adf2b380-f32a-4333-b49e-e1a2c0eb8a11
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1084645
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.68(b)Backup file not maintained
- 21 CFR 211.68(b)input/output verification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Swiss Pharmaceutical Company Ltd
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 12, 2025 | Not classified | Office of Inspections and Investigations | |
| May 12, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Swiss Pharmaceutical Company Ltd
- FDA Inspection 1288280 - 2025-09-12
- FDA Inspection 1019198 - 2017-05-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.